A

Argenx

Organization

Heard in 13 episodes across 4 shows since Jun 2026

Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. The company focuses on the development of antibody therapies for the treatment of autoimmune diseases and cancer, with a primary emphasis on orphan drugs.

Discussed inMarkets100%

Episodes

13
across 4 shows

This week

0
episodes on 0 shows

Expert statements

5
5 positive

Share of the conversation

Mentions of Argenx per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 24Sep 15Oct 8Oct 30Nov 21
Show the data
DayShare (7-day)Mentions
Oct 130.01‰1
Oct 160.03‰2
Oct 200.03‰1
Nov 60.01‰1
Nov 100.02‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Argenx comes up on a podcast

One email a week at most, with the new episodes that mention Argenx. Free, no account needed, unsubscribe in one click.

What experts have said about Argenx

5 statements · 5 positive

  1. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx shares rose as much as 10%.

    “shares up as much as 10%.”

    Listen at 2:45

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges
  2. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx's drug helps patients with an immune-system disease.

    “this helps patients with an immune system disease.”

    Listen at 2:53

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges
  3. Louise MoonPositiveAug 17, 2026· Stock Movers

    Argenx shares rose by as much as 10%.

    “shares up as much as 10%.”

    Listen at 3:00

    Open the episode · Fresnillo AstraZeneca Climbs, Argenx Surges

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

13 episodes featuring Argenx, newest first